⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of AplusA Research and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
AplusA Research
↗Lyon, France
AplusA Research is a leading global independent market research and strategic consulting agency dedicated exclusively to the healthcare and life sciences sector. Founded in 1995, the company provides comprehensive research solutions including primary and secondary data analysis, qualitative and quantitative studies, real-world evidence, and syndicated reports to support pharmaceutical and biotech companies throughout the product lifecycle.
Headquartered in Lyon, France, with a significant international presence, AplusA leverages deep clinical and therapeutic expertise to deliver actionable insights. The firm is known for its physician-led approach and advanced analytics, helping clients navigate complex market access, competitive intelligence, and patient journey mapping across diverse therapeutic areas such as oncology, rare diseases, immunology, and CNS.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:CRO
Sub-Industry:Healthcare Market Research & Strategic Consulting
SIZE & FINANCIALS
Employees:51-200
Revenue:$30M-$50M
Founded:1995
Ownership:private
Status:operating
0
CORPORATE STRUCTURE
Key Partnerships:EPHMRA (European Pharmaceutical Market Research Association), INTELLUS, BHBIA, ISPOR
COMPETITION
Position:Leader
Competitors:Aptitude Health, Allucent, IQVIA, Clarivate
LEADERSHIP
Key Executives:
Pierre Pigeon - President & Founder
Christine Mai - EVP, Chief Sales & Marketing Officer
Kevin Kelly - COO, AplusA US
Scientific Founders:Pierre Pigeon
LINKS
Website:aplusaresearch.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with AplusA Research. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.